- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02563912
Pre-calculated Doses of Medication for Pediatric Resuscitation, a Simulation Experimental Trial
April 5, 2016 updated by: Jocelyn Gravel, St. Justine's Hospital
Pre-calculated Doses of Medication for Pediatric Resuscitation, a Simulation Cross-over Randomized Experimental Trial
Dosage errors are common in the stressful situation of a pediatric resuscitation.
In addition to that, studies have reported that delays to provide medication is associated to worst survival rate for very sick children.
To minimize delays and error, the investigators recently published a resuscitation handbook who provides drug dosages for each weight for children thus eliminating the need for dosage calculation.
Once the weight of the patient is known, the physicians only have to open the book at the page corresponding to the weight and all the medications with their calculated dosage are provided.
The primary goal of this study is to evaluate the number of dosage error during simulated pediatric resuscitation comparing residents using the handbook vs. utilisation of a chart providing non-calculated dosage.
This will be an experimental crossover trial among 40 residents performing four simulated case-scenarios in a high-fidelity simulation lab.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3T1C5
- CHU Sainte-Justine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Residents doing a rotation in pediatrics emergency medicine
Exclusion Criteria:
- Resident who participated in a previous month
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Handbook
Resuscitation handbook who provides drug dosages for each weight for children.
For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.
|
Resuscitation handbook who provides drug dosages for each weight for children.
For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.
|
|
Active Comparator: Medication chart
Medication chart who provides drug dosages for each weight for children.
For example,it is written that the dosage of epinephrin is 0.01 mg/kg.
|
Medication chart who provides drug dosages for each weight for children.
For example,it is written that the dosage of epinephrin is 0.01 mg/kg.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Having at least one dosage error in any of the medications during the case for a participant
Time Frame: During the simulation (10 minutes)
|
Difference of > 10% of the recommended drug dosage for any of the medication provided during the simulated case scenario.
To be perfect, there must be no error among all drugs provided.
|
During the simulation (10 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dosage error in any for all individual medications during the case for a participant
Time Frame: During the simulation (10 minutes)
|
Difference of > 10% of the recommended drug dosage for any of the medication provided during the simulated case scenario
|
During the simulation (10 minutes)
|
|
Time for first drug prescription for each case per participant
Time Frame: During the simulation (10 minutes)
|
Time required for the prescription of the first dose of medication.
From beginning of the case until the first dose of epinephrine is completely prescribed (Dosage included)
|
During the simulation (10 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
September 27, 2015
First Submitted That Met QC Criteria
September 29, 2015
First Posted (Estimate)
September 30, 2015
Study Record Updates
Last Update Posted (Estimate)
April 6, 2016
Last Update Submitted That Met QC Criteria
April 5, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Resuscitaion book
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.